Thrombosis in inherited factor VII deficiency

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 10, 2003, Pages 2153-2158

  Mariani, G ^a   Herrmann, F H ^b   Schulman, S ^c   Batorova, A ^d   Wulff, K ^b   Etro, D ^e   Dolce, A ^a   Auerswald, G ^f   Astermark, J ^g   Schved, J F ^h   Ingerslev, J ⁱ   Bernardi, F ^e  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Haemophilia Center   (Slovakia)

^e UNIVERSITY OF FERRARA   (Italy)

^f Kinderklinik   (Germany)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ University Hospital   (Denmark)

Author keywords

Congenital FVII deficiency; Replacement therapy; Surgery; Thrombophilia; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; FACTOR IIA; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; DATA BASE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; THROMBOPHILIA; THROMBOSIS; TIME; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; DATABASES; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR V; FACTOR VII DEFICIENCY; FACTOR XA; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PROTHROMBIN; THROMBOPHILIA; THROMBOSIS; TIME FACTORS; VENOUS THROMBOSIS;

EID: 3042822425     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00395.x     Document Type: Article

References (33)

1. Hall C, Rapaport SI, Ames SB, DeGroot JA, Allen ES, Ralston MA. A clinical and family study of hereditary proconvertin (Factor VII) deficiency. Am J Med 1964; 37: 172-81.
2. McVey JH, Boswell E, Mumford AD, Kemball-Cook G, Tuddenham EG. Factor VII deficiency and the FVII mutation database. Hum Mutat 2001; 17: 3-17.
3. Peyvandi F, Mannucci PM, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia 1997; 3: 242-6.
4. Ragni MV, Lewis JH, Spero JA, Hasiba U. Factor VII deficiency. Am J Hematol 1981; 10: 79-88.
5. Godal HC, Madsen K, Nissen-Meyer R. Thromboembolism in patients with total proconvertin (Factor VII) deiciency. A report of two cases. Acta Med Scand 1962; 171: 325-7.
6. Gerswin ME, Gude JK. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency. N Engl J Med 1973; 288: 141-2.
7. Solanski DL, Corn M. Thromboembolism in patients with hereditary deficiency of coagulation factors. South Med J 1980; 73: 944-6.
8. Shifter T, Machtey I, Creter D. Thromboembolims in congenital factor VII deficiency. Acta Haematol 1980; 71: 60-2.
9. Lefrére JJ, Chaunu MP, Conard J, Horellou MH, Samama M. Congenital factor VII deficiency and cerebrovascular stroke Lancet 1985; 2: 1006-7 (Letter).
10. Nakagawa K, Furusawa A, Momono S, Sasaki Y, Ujiie K. Gastrectomy for a patient with congenital factor VII deficiency: a case report. Nippon Geka Gakkai Zasshi 1990; 91: 771-3.
11. Schulman S, Johnsson H, Lindmarker P. Thrombotic complications after substitution with a FVII concentrate. Thromb Haemost 1991; 66: 619 (Letter).
12. Escoffre M, Zini JM, Schliamser L, Mazoyer E, Soria C, Dupey E, Tobelem G. Severe arterial thrombosis in a congenitally factor VII deficient patient. Br J Haematol 1995; 91: 739-1.
13. Worth LL, Hoots WK. Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deicient infant. Haemophilia 1998; 4: 757-61.
14. Mariani G, Herrmann F, Bernardi F, Schved JF, Auerswald G, Ingerslev J. Clinical manifestations, management and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII deficiency. Blood 2000; 96: 374 (Letter).
15. Wulff K, Herrmann FH. Twenty-two novel mutations of the factor VII gene in factor VII Deficiency. Hum Mutat 2000; 15: 489-96.
16. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.
17. Quere I, Perneger TV, Zittoun J, Bellet H, Gris JC, Daures JP, Schved JF, Mercier E, Laroche JP, Dauzat M, Bounameaux H, Janbon C, deMoer-loose P. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet 2002; 359: 747-52.
18. Perry DJ, Pasi. KJ, eds. Methods in Molecular Medicine. Hemostasis and Thrombosis Protocols. Totowa, NJ: Humana Press, 1999.
19. Faioni EM, Franchi F, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Finazzi G, Mannucci PM. Coinheritance of the HR2 haplo-type in the factor V gene confers an increased risk of venous thrombo-embolism to carriers of factor V R506Q. Blood 1999; 94: 3062-6.
20. Pinotti M, Etro D, Bindini D, Papa ML, Roderigo G, Rocino A, Mariani G, Ciavarella N, Bernardi F. Residual factor VII activity and different hemorrhagic phenotypes in CRM (+) factor VII deficiencies (Gly331-Ser and Gly283Ser). Blood 2002; 99: 1495-7.
21. Arbini AA, Bodkin D, Lapaciuk S, Bauer KA. Molecular analysis of Polish patients with factor VII deficiency. Blood 1994; 84: 2214-20.
22. Bernardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Redaelli R, Ballerini G, Pamberton S, Wacy AI, Mariani G, Tuddenham EDG, Marchetti G. Molecular defects in CRM+ factor VII deiciencies. modelling of missense mutations in the catalytic domain of FVII. Br J Haematol 1994; 86: 610-8.
23. Toso R, Pinotti M, High KA, Pollak ES, Bernardi F. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. Biochem J 2002; 363: 411-6.
24. Bernardi F, Castaman G, Redaelli R, Pinotti M, Lunghi B, Roderigo F, Marchetti G. Topologically equivalent mutations causing dysfunctional coagulation factor VII (294Ala→Val) and X (334Ser→Pro). Hum Mol Genet 1994; 3: 1175-7.
25. Millar DS, Kemball-Cook G, McVey JH, Tuddenham EG, Mumford AD, Attack GB, Reverter JC, Lanir N, Parapia LA, Reynaud J, Meili E, vonFelten A, Martinowitz U, Prangnell DR, Krawczak M, Cooper DN. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet 2000; 107: 327-42.
26. FVII Database Mutation 2002 Available at: http://europium.mrc.rpm-s.ac.uk.
27. Zhang E, St Charles R, Tulinsky A. Structure of extracellular tissue factor complexed with factor VIIa inhibited by BPTI mutant. J Mol Biol 1999; 285: 2089-104.
28. Iakhiaev A, Ruf W, Rao LVM. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor. Thromb Haemost 2001; 85: 458-63.
29. Perona JJ, Craik CS. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. JBC 1997; 48:29987-90.
30. Astermark J, Tengborn L, Hedner U, Berntorp E. Anti- and procoagulant activities in factor VII-deficient subjects. Thromb Res 2001; 101:435-40.
31. Koehler M. Thrombogenicity of prothrombin complex concentrates. Thromb Res 1999; 95: 13-7.
32. Cedarbaum AI, Blatt PM, Roberts HR. Intravascular coagulation with use of human prothrombin complex concentrates. Ann Intern Med 1976; 84: 683-7.
33. Blaizot MG, Biron-Andreani C, Aguilar-Martinez P, deMoerloose P, Briquel MF, Goudemand J, Stieltjes N, Barrot C, Chambost H, Durin A, Gay V, Peynet J, Poujmajou K, Schved JF. Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding. Br J Haematol 2002; 117: 172-5.